Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aytu BioScience Q4 Sales $23.50M Beat $20.90M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly sales of $23.50 million which beat the analyst consensus estimate of $20.90 million by 12.44 percent. This is a 58.13 percent increase over sales of $14.86 million the
byBenzinga Newsdesk
September 27, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aytu BioScience (NASDAQ:AYTU) reported quarterly sales of $23.50 million which beat the analyst consensus estimate of $20.90 million by 12.44 percent. This is a 58.13 percent increase over sales of $14.86 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0